electroCore Provides Update on Availability of gammaCore Sapphire™ CV for the Acute Treatment of Asthma Exacerbations in Known or Suspected COVID-19 Patients July 30, 2020
https://investor.electrocore.com/news-releases/news-release-details/electrocore-provides-update-availability-gammacore-sapphiretm-cv
Initial distribution to hospitals and patients expected to begin on July 31st
BASKING RIDGE, N.J., July 30, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced more information about availability, distribution and pricing for gammaCore Sapphire™ CV non-invasive vagus nerve stimulation (nVNS) therapy under its Emergency Use Authorization (EUA). The EUA allows for the use of gammaCore Sapphire™ CV at home or in a healthcare setting to acutely treat adult patients with known or suspected COVID-19 who are experiencing exacerbation of asthma-related dyspnea and reduced airflow, and for whom approved drug therapies are not tolerated or provide insufficient symptom relief.
“We are pleased to be ready to make gammaCore Sapphire CV available to treat people with known or suspected COVID-19 who are experiencing exacerbation of asthma-related breathing difficulty,” said Dan Goldberger, Chief Executive Officer of electroCore. “Our goal is to make this process as simple as possible for all of the patients, physicians and hospitals that would like to use gammaCore Sapphire CV, and we have engaged Premier Pharmacy Services, a national specialty pharmacy, to support its distribution.”
Stephen Samuel, Chief Executive Officer of Premier Pharmacy Services, stated, “At Premier, our mission every day is to help our patients manage complex diseases, and we are pleased to partner with electroCore to offer gammaCore Sapphire CV therapy to COVID-19 patients in need.”
gammaCore Sapphire CV (nVNS) Logistical Information
Availability: July 31, 2020
Message in reply to:
ECOR- the value of the PR isn’t the hardware price -this little company would be immediately profitable if they gave away the units and just sold prescription software over the phone - the $1250 is merely gravy - what the COVID market will bear. (Which will squeeze bears).
To follow KarinCA, click here then click "Follow This Member" under my photo.
Be kinder than necessary, for everyone you meet is fighting some kind of battle.
Recent ECOR News
- electroCore to Announce Second Quarter June 30, 2024 Financial Results on Wednesday, August 7, 2024 • GlobeNewswire Inc. • 07/31/2024 12:00:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 07/23/2024 04:09:24 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 07/23/2024 04:15:08 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 07/18/2024 07:40:06 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 07/17/2024 09:15:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2024 09:06:03 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 07/10/2024 08:07:23 PM
- electroCore Announces the Commercial Launch of TAC-STIM™ • GlobeNewswire Inc. • 06/25/2024 12:00:00 PM
- electroCore to Join Russell Microcap® Index • GlobeNewswire Inc. • 06/11/2024 12:00:00 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 06/07/2024 08:33:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:30:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:05:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 12:32:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 12:31:35 PM
- electroCore, Inc. Announces Closing of $9.3 Million Registered Direct Offering and Concurrent Private Placements Priced At Market Under Nasdaq Rules • GlobeNewswire Inc. • 06/06/2024 12:00:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 06/04/2024 08:07:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 02:26:23 PM
- electroCore, Inc. Announces $9.3 Million Registered Direct Offering and Concurrent Private Placements Priced At Market Under Nasdaq Rules • GlobeNewswire Inc. • 06/03/2024 12:30:00 PM
- Firefly Neuroscience, an AI-Driven Brain Health Company, Names Brian S. Posner to its Board of Directors, Upon Closing of Its Merger Transaction with WaveDancer • GlobeNewswire Inc. • 05/29/2024 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 08:18:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 08:15:09 PM
- electroCore Announces First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/08/2024 08:05:00 PM
- electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 05/03/2024 08:05:00 PM
Duane Forrester Joins INDEXR as SVP of Search • MONI • Jul 31, 2024 11:46 AM
Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM
Kona Gold Beverage Significantly Reduces Debt from Multiple Holders • KGKG • Jul 31, 2024 9:00 AM
Avant Technologies Opens Equity Line with GHS Investments as Company Explores Expansion into Additional Technologies • AVAI • Jul 30, 2024 8:00 AM
ELEMENT79 GOLD CORP PROVIDES UPDATE ON CHACHAS COMMUNITY CHARTER AND REVENUE GENERATION, M&A ACTIVITIES • ELMGF • Jul 30, 2024 8:00 AM
INDEXR AI Merges With Moon Equity Holdings Corp. (MONI), Creating a Leading-edge Technology Company • MONI • Jul 29, 2024 9:59 AM